ASML vs AWRE

ASML exhibits strong financial health with a Piotroski F-Score of 4/9, indicating stable fundamentals despite not reaching the 'strong' threshold. The company's robust profitability metrics—especially a 50.46% ROE and 29.42% profit margin—underscore its operational excellence. While the current price of $1,345.69 trades at a premium to both the Graham Number ($193.99) and Intrinsic Value ($507.83), this is justified by exceptional growth prospects and dominant market positioning in semiconductor equipment. The recent earnings beat rate of 50% over the last four quarters and consistent positive surprises support a bullish outlook. The absence of an Altman Z-Score does not indicate distress risk, as the company maintains a low debt-to-equity ratio (0.24) and strong liquidity. Price trades at a 28.2% premium to fair value estimate ($1050.00), limiting near-term upside from a valuation perspective.

The Advanced Deterministic Scorecard reveals a weak financial health profile with a Piotroski F-Score of 3/9, indicating significant operational and profitability concerns. Despite strong gross margins and robust year-over-year revenue growth of 33.3%, the company continues to report negative profit and operating margins, resulting in negative ROE and ROA. The absence of an Altman Z-Score prevents a full distress risk assessment, but the current negative earnings and lack of valuation metrics suggest elevated risk. While insider sentiment is moderately positive at 60/100, technical trend signals are bearish, and recent price performance shows deterioration over the medium term.